| Literature DB >> 25270874 |
Charlotte Whitmore1, Jennifer Morgan.
Abstract
There are over 30 mouse models with mutations or inactivations in the dystrophin-associated protein complex. This complex is thought to play a crucial role in the functioning of muscle, as both a shock absorber and signalling centre, although its role in the pathogenesis of muscular dystrophy is not fully understood. The first mouse model of muscular dystrophy to be identified with a mutation in a component of the dystrophin-associated complex (dystrophin) was the mdx mouse in 1984. Here, we evaluate the key characteristics of the mdx in comparison with other mouse mutants with inactivations in DAPC components, along with key modifiers of the disease phenotype. By discussing the differences between the individual phenotypes, we show that the functioning of the DAPC and consequently its role in the pathogenesis is more complicated than perhaps currently appreciated.Entities:
Keywords: dystroglycan; dystrophin; mdx; mouse models; muscular dystrophy
Mesh:
Substances:
Year: 2014 PMID: 25270874 PMCID: PMC4285463 DOI: 10.1111/iep.12095
Source DB: PubMed Journal: Int J Exp Pathol ISSN: 0959-9673 Impact factor: 1.925